Home
About Conference
Welcome Message
Conference Overview
Organization
Floor Plan
Announcement
Program
Program at a Glance
Day 1 (Aug. 31)
Day 2 (Sep. 1)
Registration
Guidelines (Overseas)
Guidelines (Domestic)
Online Submission
Modification
Lecture Material
Guidelines
Online Submission
Modification
Download Center
Abstract
Guidelines
Online Submission
Modification
Sponsorship
Sponsor Lounge
Information
Venue
Transportation
Accommodation
Discover Seoul, Korea
VISA
menu
Home
Program - Day 1 (Aug. 31, 2024)
Click the Button to check time for each country where you are located.
Room A
Time
Program
Chair / Speaker
09:25-09:30
Opening Remark
CHOE Yong Beom
(President of the 2nd ASP 2024 Seoul)
09:30-09:35
Congratulatory Message
OZAWA Akira
(President of ASP)
09:35-09:40
KANG Hoon
(President of KDA)
09:40-09:55
Meeting report from ASP
09:40-09:50
Reflecting on Achievements: A Comprehensive Review of the 1st ASP
MABUCHI Tomotaka
(Japan)
09:50-09:55
Setting New Horizons: Visions and Preparations for ASP 2024
KIM Byung Soo
(Secretary General of the 2nd ASP 2024 Seoul)
09:55-10:15
Plenary lecture 1: The Past, Present and Future Perspective of ASP
TBD
YOUN Jai Il
(Korea)
10:15-11:25
The Role of Dermatologists in Psoriatic Arthritis (Panel Discussion 1)
10:15-10:25
Management of Treating Psoriatic Arthritis
10:25-10:35
Clinical Settings and Experiences in Japan
10:35-10:45
Clinical Settings and Experiences in Vietnam
10:45-10:55
Rheumatologist's Perspective
10:55-11:25
Discussion
11:25-11:35
Group Photo
11:35-12:55
Luncheon Symposium #1 (Jansen)
Guiding New Perspectives in Psoriasis: Can We Modify Psoriasis Disease Course?
SCHAKEL Knut
(Germany)
12:55-13:25
Invited Lecutre #1
Recent Landscape in Psoriasis Management
MORITA Akimichi
(Japan)
13:25-13:55
Invited Lecutre #2
From Bench to Bedside: The Future Path of Psoriasis Treatment Development
CHO Raymond J
(USD)
13:55-14:25
Invited Lecutre #3
Asia Pacific Consensus Recommendations for the Management of Generalized Pustular Psoriasis
CHOON Siew Eng
(Malaysia)
14:25-15:05
Coffee break and Poster Rounding
15:05-16:15
Comparative Landscapes of Psoriasis across Asia- Epidemiology and Healthcare Systems
(Panel Discussion 2)
15:05-15:15
Korea
KIM Jeong Eun
(Korea)
15:15-15:25
Japan
YAMAGUCHI Yukie
(Japan)
15:25-15:35
Philippines
GUEVARA Bryan
(Philippines)
15:35-15:45
Malaysia
AZURA Mohd Affandi
(Malaysia)
15:45-16:15
Panel Discussion
16:15-17:25
Exploring Psoriasis Treatment Goals and Modalities in Asian Countries
(Panel Discussion 3)
16:15-16:25
Korea
BANG Chul Hwan
(Korea)
16:25-16:35
China
CHEN Xi-Bei
(China)
16:35-16:45
Singapore
THENG Colin
(Singapore)
16:45-16:55
Indonesia
WAHYUDI Danang Tri
(Indonesia)
16:55-17:25
Panel Discussion
Room B
Time
Program
Chair / Speaker
10:15-11:25
Practical Tips in Treating Psoriasis Patients
10:15-10:35
Patient Education
KIM Yoon-Seob
(Korea)
10:35-10:55
Interdepartment Consultation
JUNG Hye Jung
(Korea)
10:55-11:15
Frequently Asked Questions from Patients
KIM Hei Sung
(Korea)
11:15-11:25
Q & A and Discussion
11:25-11:35
Group Photo
11:35-12:55
Luncheon Symposium #2 (BMS)
Oral TYK2 inhibitor Deucravacitinib: Long-term efficacy and safety profile
ARMSTRONG April Wang
(US)
12:55-13:40
Sponsor Lecture by Boehringer Ingelheim
Targeting IL-36 in GPP: Treatment Goals & Current Learnings
(Japanese Real World Cases)
TADA Yayoi
(Japan)
13:40-14:25
Sponsor Lecture by UCB
The Future of Psoriasis Management with Advanced MOA
14:25-15:05
Coffee break and Poster Rounding
15:05-16:05
The Next Era of Psoriasis Treatment
15:05-15:25
Biosimilars for Psoriasis and Psoriatic Arthritis
PARK Eun Joo
(Korea)
15:25-15:45
Stem Cell Therapy for Psoriasis
KUANG Yehong
(China)
15:45-16:05
Upcoming Therapeutics in Psoriasis
JO Seong-Jin
(Korea)
16:05-17:25
Research Session
16:05-16:25
MyD88-DC-CXCL16 axis Results Neutrophil Activation to Elicit Inflammatory Response in Pustular Psoriasis
SHI Yuling
(China)
16:25-16:45
Mature IL-36γ Induces Stratum Corneum Exfoliation in Generalized Pustular Psoriasis by Suppressing Corneodesmosin
IMAFUKU Shinichi
(Japan)
16:45-17:05
The Role of Xenobiotics in Psoriasis
CHUNG Bo Young
(Korea)
17:05-17:25
Semaphorin 4A and Psoriasis
FUJIMOTO Manabu
(Japan)